ArticleThe Journal of antimicrobial chemotherapy2022

Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge.

Nicholas Piccicacco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.